Search

Home
News
Fortune 500
Tech
Finance
Leadership
Lifestyle
Rankings
- Analytics
Multimedia

Home
News
Fortune 500

Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work

Tech

Tech
AI
Innovation
Cybersecurity

Finance

Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto

Leadership

Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative

Lifestyle

Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education

Rankings

Rankings
Analytics

Multimedia

Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts

Asia
Europe
Analytics

home

home
asthma

asthma

The U.S. is facing a shortage of the life-saving asthma drug albuterol. Here’s what to know

The U.S. is facing a shortage of the life-saving asthma drug albuterol. Here’s what to know

March 8, 2023

SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS

Novartis Asthma Pill Shows Promise in Small Trial

August 6, 2016

Fortune

How To Make Sense Of Sensor Data

By Jonathan Vanian

May 18, 2016

Most Popular

AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By Sasha Rogelberg
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By Nick Lichtenberg
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By Nick Lichtenberg

Rankings

100 Best Companies
Fortune 500
Global 500
Fortune 500 Europe

Most Powerful Women
Future 50
World’s Most Admired Companies
See All Rankings

Sections

Finance
Leadership
Success
Tech

Asia
Europe
Environment
Fortune Crypto

Health
Retail
Lifestyle
Politics

Newsletters
Magazine
Features
Commentary

MPW
CEO Initiative
Conferences
Personal Finance
Education

Customer Support

Frequently Asked Questions
Customer Service Portal
Privacy Policy
Terms of Use
Single Issues for Purchase
International Print

Commercial Services

Advertising
Fortune Brand Studio
Fortune Analytics
Fortune Conferences
Business Development

About Us

About Us
Editorial Calendar
Press Center
Work at Fortune
Diversity and Inclusion
Terms and Conditions
Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.